Anthony Belanger

Dr. Anthony Belanger

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
JLJelena Levi
Jelena Levi
CGCaroline Guglielmetti
Caroline Guglielmetti
THTimothy J Henrich
Timothy J Henrich
JYJohn C. Yoon
John C. Yoon
PGPrafulla C. Gokhale
Prafulla C. Gokhale
HCHee-Don Chae
Hee-Don Chae
Brown and brown-like adipose tissues have attracted significant attention for their role in metabolism and therapeutic potential in diabetes and obesity. Despite compelling evidence of an interplay between adipocytes and lymphocytes, the involvement of these tissues in immune responses remains largely unexplored. This study explicates a newfound connection between neuroinflammation and brown- and bone marrow adipose tissue. Leveraging the use of [18F]F-AraG, a mitochondrial metabolic tracer capable of tracking activated lymphocytes and adipocytes simultaneously, we demonstrate, in models of glioblastoma and multiple sclerosis, the correlation between intracerebral immune infiltration and changes in brown- and bone marrow adipose tissue. Significantly, we show initial evidence that a neuroinflammation-adipose tissue link may also exist in humans. This study proposes the concept of an intricate immuno-neuro-adipose circuit, and highlights brown- and bone marrow adipose tissue as an intermediary in the communication between the immune and nervous systems. Understanding the interconnectedness within this circuitry may lead to advancements in the treatment and management of various conditions, including cancer, neurodegenerative diseases and metabolic disorders.

25 August 2017 in MedChemComm
Verified
Journal Article
Closed access
PDF file
JIJames Inkster
James Inkster
SZS. Zhang
S. Zhang
VAV. Akurathi
V. Akurathi
ABAnthony Belanger
Anthony Belanger
SDS. Dubey
S. Dubey
APAlan Packard
Alan Packard
Synthesis of the tosyl precursor ( 2 ) facilitates automated synthesis of 18 F-labeled rhodamine 6G, a potential PET myocardial perfusion tracer.

31 January 2024 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Open access
SAShin Hye Ahn
Shin Hye Ahn
ABAnthony Belanger
Anthony Belanger
While automated modules for F‐18 and C‐11 radiosyntheses are standardized with features such as multiple reactors, vacuum connection and semi‐preparative HPLC, labeling and processing of compounds with radiometals such as Zr‐89, Lu‐177 and Ac‐225 often do not require complex manipulations and are frequently performed manually by a radiochemist. These procedures typically involve transferring solutions to and from vials using pipettes followed by heating of the reaction mixture, and do not require all the features found in most commercial automated synthesis units marketed as F‐18 or C‐11 modules. Here we present an efficient automated method for performing radiosyntheses involving radiometals by adapting a commercially available robotic pipettor originally developed for high‐throughput processing of biological samples. While a robotic pipettor is less costly than a radiosynthesis module, it holds many similar advantages over manual radiosynthesis such as minimization of operator error, lower operator exposure rates, and abbreviated synthesis times, among others. To demonstrate the feasibility of using the OpenTrons OT‐2 robotic pipettor to perform automated radiosyntheses, we radiolabeled and formulated 177Lu‐PSMA‐617 and 225Ac‐PSMA‐617 on the system. The OT‐2 was then used to help streamline the quality control process for both products, further minimizing manual handling by and exposure to the radiochemist.

18 October 2023 in Molecules
Verified
Journal Article
Open access
PDF file
TLTalakad Goolaiah Lohith
Talakad Goolaiah Lohith
CKCharalambos Kaittanis
Charalambos Kaittanis
ABAnthony Belanger
Anthony Belanger
SAShin Hye Ahn
Shin Hye Ahn
PSPhil Sandoval
Phil Sandoval
PMPaul McQuade
Paul McQuade
Success of gene therapy relies on the durable expression and activity of transgene in target tissues. In vivo molecular imaging approaches using positron emission tomography (PET) can non-invasively measure magnitude, location, and durability of transgene expression via direct transgene or indirect reporter gene imaging in target tissues, providing the most proximal PK/PD biomarker for gene therapy trials. Herein, we report the radiosynthesis of a novel PET tracer [18F]AGAL, targeting alpha galactosidase A (α-GAL), a lysosomal enzyme deficient in Fabry disease, and evaluation of its selectivity, specificity, and pharmacokinetic properties in vitro. [18F]AGAL was synthesized via a Cu-catalyzed click reaction between fluorinated pentyne and an aziridine-based galactopyranose precursor with a high yield of 110 mCi, high radiochemical purity of >97% and molar activity of 6 Ci/µmol. The fluorinated AGAL probe showed high α-GAL affinity with IC50 of 30 nM, high pharmacological selectivity (≥50% inhibition on >160 proteins), and suitable pharmacokinetic properties (moderate to low clearance and stability in plasma across species). In vivo [18F]AGAL PET imaging in mice showed high uptake in peripheral organs with rapid renal clearance. These promising results encourage further development of this PET tracer for in vivo imaging of α-GAL expression in target tissues affected by Fabry disease.